Background. Many studies have combined patients with hemodynamically well-tolerated ventricular tachycardia (VT) and those with cardiac arrest (CA) as a single, homogenous group. Recent studies suggest that these two groups have different electrophysiological substrates and responses to therapy. Most of these studies, however, enrolled patientswith a variety of cardiac diagnoses.
Methods and Results. We used signal-averaged electrocardiography (SAECG) and endocardial catheter mapping to define the electrophysiological substrate in patients with coronary artery disease and VT or CA and correlate the results of the two methods. We also examined the usefulness of SAECG in CA patients to differentiate those with inducible arrhythmias from those who are noninducible. VT patients were more likely to have had a prior myocardial infarction (p=0.0005) and to have inducible arrhythmias (p=0.O001) than were CA patients. The induced arrhythmias in patients who presented with VT was VT in more than 90% of cases, whereas in CA patients, polymorphic ventricular tachycardia (PMVT) accounted for one third of induced arrhythmias.
Mean filtered QRS duration was longer (135 versus 120 msec) and the terminal QRS voltage was smaller (20 versus 34,V) in VT than in CA patients (p<0.01). Sixty-three percent of CA patients and 87% of VT patients had abnormal SAECG (p=0.001). VT patients had more extensive endocardial abnormalities and more abnormal (53% versus 40%, p=0.002), fractionated (8% versus 3%o,p=0.02), late (17% versus 8%,p=0.0003), and late abnormal or fractionated (14% versus 4%,p=0.0001) sites than CA patients. VT patients had a greater duration of the longest electrogram (129 versus 109 msec, p=0.0006) and total endocardial activation time (68 versus 54 msec, p=0.009). Among CA patients, those with induced VT had more extensive substrate than did those with induced PMVT and were similar to VT patients with induced VT. Among CA patients, the trend for more patients with inducible VT (77%) or PMVT (55%) than noninducible patients (47%) to have an abnormal SAECG did not reach statistical significance (p=0.14). The positive and negative predictive values of an abnormal SAECG were 77%O and 44%, respectively.
Conclusions. VT patients have more extensive endocardial substrate than CA patients, which translates into greater and more frequent SAECG abnormalities. Among CA patients, there are significant differences in substrate between patients with induced VT and those with induced PMVT. SAECG is not useful in differentiating CA patients who have inducible VT or PMVT from those who do not. (Circulation 1991;84:672-678) S ignal-averaged electrocardiography (SAECG) layed electrograms and suggest the presence of an has been used extensively to detect low-am-electrophysiological substrate for ventricular tachyplitude, high-frequency signals at the end of cardia (VT).12 The structure of subendocardial laythe QRS on the body surface.12 These late potentials ers from which VT arises has been demonstrated to have been shown to correlate with fragmented, de-comprise normal myocytes separated by fibrous bands of scar tissue.3 Endocardial recordings from this arrhythmogenic substrate characteristically demonstrate abnormal or fractionated activity. SAECG has been applied in a variety of settings.1,4,5 Many studies evaluating SAECG in patients with ventricular tachyarrhythmias have enrolled both patients with sustained, uniform VT and those with cardiac arrest (CA) and considered them as a single group.4'5 Recent studies using electrophysiological testing6-10 or SAECG8"11,2 have suggested that these two groups of patients have distinct and different electrophysiological substrates. However, most of these latter studies enrolled patients with a variety of underlying cardiac diagnoses.79,11"12 The electrophysiological substrate of ventricular arrhythmias in coronary artery disease differs from that of cardiomyopathy as assessed by SAECG,13 endocardial mapping,10 or electrophysiological testing. [13] [14] [15] Thus, in attempting to distinguish CA patients from VT patients, researchers have introduced another confounding variable by including a mixture of patients with different types of underlying heart disease.
Only one study has previously attempted to correlate the results of SAECG and ventricular mapping in patients with coronary artery disease who had either VT or CA.8 These investigators used intraoperative epicardial mapping and reported on a small number of patients who underwent both procedures. Although it has been suggested that epicardial sites may play a critical role in the genesis of some VT,16 in the majority of cases, the substrate for VT in patients with coronary heart disease is in the subendocardial layers.17"8 Late potentials recorded from the epicardium are neither sensitive nor specific indicators of the site of origin of VT. 19 We therefore undertook the present study to define differences in SAECG of patients with coronary artery disease who present with either CA or VT and correlate the SAECG findings with the results of endocardial sinus rhythm catheter mapping. By enrolling only patients with coronary artery disease, we avoided the confounding influence of heterogeneity of underlying cardiac disease. We hypothesized that patients with coronary artery disease and VT would have a greater degree of SAECG abnormalities than would patients with CA. Furthermore, the differences in SAECG parameters should correlate with differences in endocardial catheter mapping indexes of abnormal electrophysiological substrate. In addition, we investigated whether SAECG is useful in predicting the induciblity of sustained arrhythmias in patients who present with CA.
Methods
We studied 133 patients who were evaluated by SAECG and electrophysiological study including left ventricular endocardial mapping. All patients had angiographically documented coronary artery disease, and none had recent (less than 4 weeks) myocardial infarction. Eighty-five patients had presented with sustained, tolerated, uniform VT; 48 patients were evaluated after an episode of out-ofhospital CA (witnessed sudden death requiring prehospital resuscitation). Patients with bundle branch block were excluded. Patients in the two groups were compared in terms of age, gender, ejection fraction, number of diseased coronary arteries (defined as 70% or greater obstruction), history of myocardial infarction (either a documented hospital admission for chest pain with corroborating enzymatic and electrocardiographic changes or the finding at catheterization of coronary occlusion associated with focal wall motion abnormalities), and inducibility of VT or polymorphic ventricular tachycardia (PMVT).
Electrophysiological Studies and Catheter Mapping
Studies were performed in patients in the nonsedated, postabsorptive state. Our stimulation protocol has been previously described and includes the introduction of one, two, and three extrastimuli at two right ventricular sites at a minimum of two pacing cycle lengths and rapid ventricular pacing.20 Stimulus strength was set at twice diastolic threshold, and pulse width was 1.0 msec. Stimulation proceeds until a sustained and hemodynamically compromising tachyarrhythmia is induced or refractoriness of the extrastimuli is reached.
The left ventricular mapping scheme has been previously described.10 Local electrograms were recorded at each of 12 predesignated sites, each representing approximately 4-8 cm2. Recordings were made via quadripolar (5-mm interelectrode distance) catheters. Catheter position was confirmed by multiplane fluoroscopy, and stability was ensured by recording for a minimum of 30 seconds. Electrograms were recorded with a 10-mm interelectrode distance (first and third poles) with both fixed-gain (1 mV/cm) and variable-gain amplification. Electrograms were filtered at 30-500 Hz and recorded on analog magnetic tape (model 5600C, Honeywell) and a 16channel ink-jet recorder (Siemens Elema Mingograf) at a paper speed of 200 mm/sec. Electrograms were classified as normal, abnormal, or fractionated based on criteria for amplitude, duration, and an amplitude-to-duration ratio previously reported.21 A normal electrogram had an amplitude of 3 mV or more, a duration of 70 msec or less, and/or an amplitude-to-duration ratio of 0.046 or more. A fractionated electrogram had an amplitude of 0.5 mV or less, a duration of 133 msec or more, and/or an amplitude-to-duration ratio of 0.005 or less.
Early electrograms were those exhibiting activity preceding the surface QRS. Late electrograms were defined as any type of electrogram having components that extended beyond the end of the surface QRS. Offset of endocardial activation was defined as the latest electrical activity recorded in the latest electrogram as measured from the start of the QRS.
Local activation time at a site was defined as the time from onset of the surface QRS to the time at which the largest rapid deflection of the local electrogram crossed the baseline. Total endocardial activation time was defined as the time from the earliest local activation to the latest local activation. The endocardial activation time, duration of the longest electrogram recorded, presence of late abnormal or fractionated electrograms, and offset of the latest electrogram were taken as indicators of slow endocardial conduction velocity.
Sustained VT was defined as tachycardia of uniform morphology that lasts longer than 30 seconds or causes hemodynamic collapse. Nonsustained ventricular tachycardia was defined as VT of at least three complexes (non-bundle branch reentry) lasting as long as 30 seconds and not requiring cardioversion. Sustained PMVT was defined as tachycardia of multiple morphologies lasting longer than 30 seconds or causing hemodynamic collapse. Signal-Averaged Electrocardiography SAECG was performed on an Arrhythmia Research Technology high-resolution electrocardiograph. Recordings were processed and analyzed as previously described. 22 High-pass filtering was performed at 25 Hz, and SAECG was considered abnormal if the filtered QRS duration was longer than 114 msec or the root-mean-square voltage of the last 40 msec of the filtered QRS complex was 25 ,uV or less.
Statistical Analysis
X2 Analysis and analysis of variance were used as indicated in assessing differences in variables between VT and CA patients. To define the correlates of SAECG variables, multiple regression analysis was performed with the aforementioned clinical variables and indexes of abnormal substrate as the independent variables.
Results
The clinical characteristics of VT and CA patients are compared in Table 1 . The two groups were similar in terms of age, gender, ejection fraction, and number of diseased coronary arteries. VT patients were significantly more likely to have sustained a previous myocardial infarction than were CA patients (96% versus 77%, p=0.0005) and to have a ventricular aneurysm (85% versus 63%, p=0.002). Eighty-two VT patients (97%) had inducible VT or PMVT compared with 33 CA patients (68%) (p=0.0001). Thirty-three of the VT patients (40%) and 13 of the CA patients (27%) were studied while taking antiarrhythmic medications (p=NS). Table 2 gives SAECG data from the two groups of patients. Shown are results of SAECG for all patients as well as information excluding patients with different degrees of intraventricular conduction delays. For all of the analyses, the VT patients had significantly greater filtered QRS duration and lower root-mean-square voltage of the terminal 40 msec.
The results of endocardial mapping are presented in Table 3 . Compared with CA patients, VT patients had a greater percentage of sites with abnormal (53% versus 40%, p=0.002) and fractionated (8% versus 3%,p=0.02) electrograms. VT patients had a greater duration of the longest electrogram (117 versus 101 msec, p=0.0004), a longer total endocardial activation time (68 versus 54 msec, p=0.009), and a later offset (129 versus 109 msec, p=0.0006). The two groups did not differ in the percentage of sites demonstrating early activity (11% versus 14%, p=0.22). VT patients had a greater percentage of late sites (17% versus 8%,p=0.0003) and of late sites exhibiting abnormal or fractionated activity (14% versus 4%, p =0.0001). If we exclude patients studied while taking antiarrhythmic medication, all of the above analyses of SAECG and endocardial catheter mapping data remain essentially unchanged.
Multiple regression analysis revealed only the offset of the latest electrogram to significantly correlate with SAECG duration (Figure 1, p<0 .01). Offset of the latest electrogram and the percentage of sites that were late and abnormal or fractionated correlated with the amplitude of the last 40 msec in an inverse fashion (p<0.01 and p<0.05, respectively). The results of the multiple regression analysis were the same whether we combined VT and CA patients or analyzed the two groups separately.
There was a trend for the SAECG to be abnormal more frequently in CA patients who had inducible VT (77%) or PMVT (55%) than in those who did not (47%) (Figure 2 ), but this did not reach statistical significance (p=0.14). The predictive positive and negative values of SAECG were 77% and 44%, respectively. Data from sinus mapping in these three subgroups of CA patients are presented in Table 4 . On a number of indexes of abnormal conduction, patients with inducible VT had more extensive sub- strate than did those with PMVT or who were noninducible. Conversely, patients who were noninducible had less extensive substrate than either inducible group. Because of the difference between CA patients with inducible VT and CA patients with inducible PMVT, we undertook a comparison of VT patients with inducible VT and CA patients with inducible VT. The results, summarized in Table 5 , reveal no differences in any of the endocardial catheter mapping or SAECG indexes with the exception of the percentage of sites demonstrating late abnormal or fractionated activity. 
Discussion
Previous studies have suggested that CA patients have a different electrophysiological substrate from VT patients as assessed by endocardial catheter mapping,10 intraoperative epicardial mapping,8 SAECG,"11'2 and electrophysiological studies.679 Many of the previous studies, however, enrolled patients with a variety of cardiac diagnoses,7'9"1",2 and only a few limited themselves to patients with coronary artery disease.68 Because patients with cardiomyopathy have a different, less well-defined electrophysiological substrate from patients with coronary artery disease, it is essential to precisely define the population to be studied. The present study is the first to examine the differences in SAECG between CA and VT patients with coronary artery disease and to correlate the SAECG findings with the results of endocardial catheter mapping.
Patients with VT had inducible arrhythmias more frequently than did patients with CA, which is in agreement with previous studies.6,7,9"11'2 Also, similar to prior reports, patients who presented with VT had VT induced more frequently, whereas PMVT was frequently induced in CA patients.6,7,9"1'12 The extent of coronary stenoses was similar for our two groups of patients, which agrees with what most7,8"11 but not all6 previous investigators have reported. The major differences between our two groups of patients were that VT patients had ventricular aneurysms and prior myocardial infarctions more often. Our study did not address the issue of ischemia because many of the patients were unable to undertake exercise testing before surgery. It is possible that CA patients have a greater frequency or degree of ischemia than VT patients.
SAECG duration and amplitude correlated with indexes of delayed conduction (offset of the latest electrogram and percentage of late and abnormal or fractionated sites) in both patient groups, confirming the ability of SAECG to identify patients with delayed, slowed conduction. Not unexpectedly, indexes of abnormal conduction occurring during the first 114 msec of the QRS did not correlate with late events in the SAECG, and the SAECG cannot be expected to distinguish patients with these abnormalities. This probably accounts for the false-negative rate of SAECG in identifying patients with abnormal substrate and ventricular tachyarrhythmias.
As a group, VT patients had longer filtered QRS durations and lower terminal amplitudes than did CA patients, which is consistent with earlier reports.81"'12 This has been reported in series limited to patients with coronary artery disease8 as well as in series enrolling patients with other diagnoses.1"12 VT patients were more likely to exhibit SAECG abnormalities than were CA patients.
In examining differences in electrophysiological substrate, we found that VT patients had more extensive substrate than did CA patients; this included greater abnormalities in indexes of late conduction that can be identified by SAECG as well as most of the indexes that do not correlate with late SAECG events. These findings agree with previous reports from our laboratory using endocardial map-ping10 and reports from other investigators using intraoperative epicardial mapping.8 Among CA patients, however, there were significant differences between patients with inducible VT and those with inducible PMVT, with the former group demonstrat- ing more extensive substrate. Furthermore, patients with induced VT had a similar degree of substrate whether they presented with CA or with VT.
The practical usefulness of SAECG in CA patients, however, appears limited. Although there was a trend for CA patients who had inducible VT or PMVT to have abnormal SAECG more frequently than those who did not have inducible arrhythmias, 30% of inducible and 47% of noninducible CA patients were misclassified by SAECG. The results of endocardial mapping paralleled the results of SAECG in that the subgroup with inducible arrhythmias had more extensive substrate than those who were noninducible, a finding previously reported from our laboratory.23
Summary
Coronary artery disease patients with CA form a group distinct from those presenting with VT in that they have less extensive anatomic substrate, which translates into less marked and less frequent SAECG abnormalities and is associated with a lower rate of inducible ventricular arrhythmias. CA patients are less likely to have sustained a prior infarction but do not differ from VT patients in terms of extent of diseased coronary arteries. Although the ejection fraction tended to be lower in patients with VT, it did not reach statistical significance. Perhaps with larger patient samples, this trend would reach significance; one would expect this because VT patients had had a prior infarction more often. Furthermore, among patients who present with CA, patients with induced VT and those with induced PMVT form distinct subgroups. CA patients with induced VT had a degree of substrate similar to that of VT patients with induced VT. We urge other investigators to distinguish among these groups of patients in future SAECG or electrophysiological studies. Among CA patients with coronary artery disease, the predictive value of SAECG is too low to permit this to be useful in identifying whether a patient will have inducible ventricular arrhythmias.
